Intralesional Fluorouracil/Epinephrine Injectable Gel for Treatment of Condylomata Acuminata
Authors:
- James M. SwinehartJSJames M. Swinehart
- Malcolm SperlingMSMalcolm Sperling
- Stephen PhillipsSPStephen Phillips
- Stephen KrausSKStephen Kraus
- Stephen GordonSGStephen Gordon
- Guy F. WebsterGWGuy F. Webster
- Robert SkinnerRSRobert Skinner
- Andrew KoreyAKAndrew Korey
- Elaine K. OrenbergEOElaine K. Orenberg
- 1 January 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 133 (1) , 67-73
Abstract
Background and Design: A new intralesional sustained-release chemotherapy is under development as a treatment for condylomata acuminata; it is administered as an injectable gel that consists of fluorouracil and epinephrine with a purified bovine collagen as the gellant (fluorouracil/epinephrine gel). In this randomized, double-blind study, we evaluated the safety and efficacy of this intralesional treatment in 401 patients, using 2 active drug formulations (fluorouracil/epinephrine gel and fluorouracil gel alone) and a placebo. Each lesion was injected once a week for up to 6 weeks, and patients were followed up for 3 months. Results: A total of 359 patients with 1926 condylomata underwent evaluation. For all lesions treated with fluorouracil/epinephrine gel, the complete response (CR) rate was 77%. For all patients treated with fluorouracil/ epinephrine gel, the CR rate was 61%. The fluorouracil/ epinephrine gel was significantly more effective (P<.002) in treating condylomata than the fluorouracil gel without epinephrine (CR rate, 43%); both were superior to placebo (CR rate, 5%). At 3 months after completion of treatment, recurrence rates in patients with CRs were as follows: fluorouracil/epinephrine gel group, 50%; fluorouracil gel group, 58%. No clinically significant drugrelated systemic reactions occurred. Finally, the type and severity of local tissue reactions of patients with a positive pretreatment collagen skin test result (6/401 [1.5%]) were similar to those of patients with a negative collagen skin test result. Conclusion: The fluorouracil/epinephrine injectable gel is a safe and effective treatment for condylomata acuminata. Arch Dermatol. 1997;133:67-73Keywords
This publication has 8 references indexed in Scilit:
- THERAPY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTIONS. PART I: INDICATIONS FOR AND JUSTIFICATION OF THERAPYInternational Journal of Dermatology, 1992
- Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation.Sexually Transmitted Infections, 1990
- The Role of Skin Testing in the Use of Collagen Injectable MaterialsThe Journal of Dermatologic Surgery and Oncology, 1989
- Results of Carbon Dioxide Laser Therapy and Topical 5-Fluorouracil Treatment for Subclinical Condyloma Found by Magnified Penile Surface ScanningJournal of Urology, 1988
- Immunity to Injectable Collagen and Autoimmune Disease: A Summary of Current UnderstandingThe Journal of Dermatologic Surgery and Oncology, 1988
- Latent Papillomavirus and Recurring Genital WartsNew England Journal of Medicine, 1985
- Treatment of anogenital warts. Comparison of trichloracetic acid and podophyllin versus podophyllin alone.Sexually Transmitted Infections, 1983
- The metabolism and pharmacology of 5‐fluorouracilJournal of Surgical Oncology, 1971